Melanoma Research Foundation

Information and Fact Sheet

Mission: To support Research for finding effective treatments and eventually a cure for melanoma.  To educate patients and physicians about the prevention, diagnosis and treatment of melanoma.  To act as an advocate for the melanoma community to raise the awareness of this disease and the need for a cure.

Purpose: The purpose of The Melanoma Research Foundation Research Grant Program is to support promising medical research that will further the goal of developing an effective treatment and possible cure of malignant melanoma, while encouraging scientists and clinicians to join in the mission.

The Foundation funds both junior and senior researchers.  In both grant programs, emphasis will be placed on projects that explore innovative approaches to understanding melanoma and its treatment.  Both basic and clinical research projects will be considered.

Junior awards (Career Development Grant) will be given to investigators who are beginning a research career emphasizing melanoma-related projects and have not yet established strong federal funding.  Up to $50,ooo per year, for two years, may be provided.

Senior awards (Established Investigator Grant) will be given to established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research.  Up to $100,000 per year, for two years, may be provided.
The following are the results of achieving Diana’s mission:

    • In January, 2006, MRF awarded eight Career Development Awards, three renewals of second-year grants and five first-year grants.  These awards have been critical to attracting new, young scientists to the field of melanoma.
    • As well, MRF awarded the first $200,000 Diana Ashby Established Investigator Award and we will award the second such award in 2007.
    • We have committed over $2,000,000 to melanoma research in the past ten years, with our commitment in 2006 alone at $850,000.

To find more information, go to http://www.melanoma.org.